| 0 |
Plasma Volume Expander [EPC] |
1 |
0.0003 |
| 1 |
Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] |
1 |
0.0002 |
| 2 |
Phosphodiesterase 3 Inhibitor [EPC] |
1 |
0.0002 |
| 3 |
CD52-directed Cytolytic Antibody [EPC] |
2 |
0.0001 |
| 4 |
Human Immunoglobulin G [EPC] |
2 |
0.0001 |
| 5 |
Acetylcholine Release Inhibitor [EPC] |
9 |
0.0001 |
| 6 |
Bile Acid Sequestrant [EPC] |
1 |
0.0001 |
| 7 |
Protease Inhibitor [EPC] |
3 |
0.0001 |
| 8 |
Nonergot Dopamine Agonist [EPC] |
1 |
0.0001 |
| 9 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
3 |
0.0001 |
| 10 |
Non-narcotic Antitussive [EPC] |
1 |
0.0001 |
| 11 |
Nitrofuran Antibacterial [EPC] |
1 |
0.0001 |
| 12 |
Cholinesterase Inhibitor [EPC] |
1 |
0.0001 |
| 13 |
Cytochrome P450 3A Inhibitor [EPC] |
3 |
0.0000 |
| 14 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 15 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
4 |
0.0000 |
| 16 |
HMG-CoA Reductase Inhibitor [EPC] |
15 |
0.0000 |
| 17 |
Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
1 |
0.0000 |
| 18 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
4 |
0.0000 |
| 19 |
Provitamin D2 Compound [EPC] |
1 |
0.0000 |
| 20 |
beta-Adrenergic Blocker [EPC] |
10 |
0.0000 |
| 21 |
Dipeptidyl Peptidase 4 Inhibitor [EPC] |
1 |
0.0000 |
| 22 |
Leukocyte Growth Factor [EPC] |
4 |
0.0000 |
| 23 |
Platelet Aggregation Inhibitor [EPC] |
13 |
0.0000 |
| 24 |
Muscle Relaxant [EPC] |
1 |
0.0000 |
| 25 |
Insulin [EPC] |
1 |
0.0000 |
| 26 |
Vitamin B12 [EPC] |
7 |
0.0000 |
| 27 |
Prostaglandin Analog [EPC] |
2 |
0.0000 |
| 28 |
Vitamin D [EPC] |
6 |
0.0000 |
| 29 |
Benzodiazepine [EPC] |
13 |
0.0000 |
| 30 |
Central alpha-2 Adrenergic Agonist [EPC] |
1 |
0.0000 |
| 31 |
Aromatic Amino Acid [EPC] |
1 |
0.0000 |
| 32 |
Folate Analog Metabolic Inhibitor [EPC] |
7 |
0.0000 |
| 33 |
Platinum-based Drug [EPC] |
4 |
0.0000 |
| 34 |
Thiazide Diuretic [EPC] |
3 |
0.0000 |
| 35 |
Vitamin C [EPC] |
6 |
0.0000 |
| 36 |
Cardiac Glycoside [EPC] |
1 |
0.0000 |
| 37 |
Anti-epileptic Agent [EPC] |
3 |
0.0000 |
| 38 |
Calcium [EPC] |
2 |
0.0000 |
| 39 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
17 |
0.0000 |
| 40 |
Non-Standardized Chemical Allergen [EPC] |
1 |
0.0000 |
| 41 |
Dihydropyridine Calcium Channel Blocker [EPC] |
4 |
0.0000 |
| 42 |
Catecholamine [EPC] |
1 |
0.0000 |
| 43 |
Histamine-1 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 44 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
1 |
0.0000 |
| 45 |
Partial Opioid Agonist [EPC] |
1 |
0.0000 |
| 46 |
5-alpha Reductase Inhibitor [EPC] |
1 |
0.0000 |
| 47 |
Expectorant [EPC] |
2 |
0.0000 |
| 48 |
Sulfonylurea [EPC] |
1 |
0.0000 |
| 49 |
Corticosteroid [EPC] |
10 |
0.0000 |
| 50 |
Phosphodiesterase 5 Inhibitor [EPC] |
1 |
0.0000 |
| 51 |
Serotonin-3 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 52 |
Interleukin-6 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 53 |
Osmotic Laxative [EPC] |
2 |
0.0000 |
| 54 |
Azole Antifungal [EPC] |
1 |
0.0000 |
| 55 |
Atypical Antipsychotic [EPC] |
2 |
0.0000 |
| 56 |
Opioid Agonist [EPC] |
1 |
0.0000 |
| 57 |
Proton Pump Inhibitor [EPC] |
2 |
0.0000 |
| 58 |
CD20-directed Cytolytic Antibody [EPC] |
1 |
0.0000 |
| 59 |
Insulin Analog [EPC] |
1 |
0.0000 |